Researchers have engineered fluorescent dual agonist probes targeting GLP1R and GIPR receptors, enabling unprecedented visualization of incretin hormone action within pancreatic and neural tissues. Published in Nature Metabolism, these probes facilitate detailed cellular mapping, accelerating understanding of metabolic hormone signaling pathways and offering potential for next-generation diabetes and neuroendocrine therapeutics development.